Silver Member: Sparrow Pharmaceuticals

Nearly 2 million Americans are on long-term corticosteroid therapy to treat diseases such as rheumatoid arthritis, asthma, vasculitis, and blood cancers. To control their disease those patients face the high adverse effects risk of corticosteroids. Drug adverse effects, of which corticosteroids are responsible for 10%, cost up to $30B per year in the US.

Sparrow Pharmaceuticals is developing safer corticosteroids. Those will provide patients a new standard of care that is effective, safe, cost-effective, and convenient. A tablet form will start […]

Silver Member: UbiVac

UbiVac is a company that offers a pipeline of groundbreaking immunotherapies in preclinical and clinical stage trials. Since 2005 the company has been engaged in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases.

UbiVac’s lead product, DPV-001 (DRibble) is a first in class DC-targeted complex vaccine/combination immunotherapy that is now in Phase II clinical trials for lung cancer. A pilot study of the vaccine is open for patients with prostate cancer, and a Phase […]

Silver Member: Vertex

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, Mass. and headquartered in Boston’s Innovation District, Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia.

In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases.

Acer Therapeutics

Acer is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer’s product candidates are believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA.

Aronora

Aronora is a translational biotechnology company engaged in the early-stage commercial development of proprietary biologic therapeutics, including recombinant monoclonal antibodies and enzymes.  Building on the company’s ground-breaking rational approaches to superior drug safety, Aronora’s product candidates have the potential to become first-in-class medical emergency therapeutics to treat life-threatening acute thrombotic vascular diseases early, in the field, even before the patient is hospitalized and the diagnosis is verified.

Cascade Custom Chemistry

Cascade Custom Chemistry, a division of Organic Consultants, Inc. (OCI), is a Contract Research Organization founded in 1980. Over the years, we have developed a reputation as a reliable and experienced partner in the pharmaceutical and specialty chemical industry.

Our services include custom chemical synthesis, synthetic route design and optimization, and synthesis of previously unknown compounds. In 2013 we opened our cGMP lab capable of several kilograms of Phase 1 cGMP manufacturing and updated our quality system accordingly. We offer a […]

Costanoan Biotechnologies

Costanoan Biotechnologies is bringing personalized therapeutics to patients with cancer. A development stage biotechnology company recently relocated to Portland, Costanoan is commercializing a unique bionanoparticle platform which produces custom, fully functionalized biocompaticle plastic nanoparticles in bacteria. The technology has been used as a vaccine against infectious diseases and is now being targeted at cancer, where its ‘tunability’ can modify the immune system for a patient’s specific tumor type.

DesignMedix

DesignMedix, Inc. develops drugs to address the large medical need caused by the rapid rise in drug resistance in multiple diseases. Diseases like malaria and diarrhea kill millions of people each year, and cause untold suffering. The World Health Organization considers drug-resistance to be one of the top three threats to human health today. Using proprietary technology, DesignMedix is developing novel drugs to help efforts to alleviate and eliminate these deadly infections.

Elex Biotech

Ventricular Arrhythmias and Heart Failure are major causes of morbidity and mortality in the world. There is a growing need for improved therapeutics, and greater recognition that we need much more effective treatments for causes of arrhythmias rather than its symptoms or sequelae. At Elex Biotech we are taking a unique rational approach toward developing new compounds that modulate the function of calcium channels that control the contraction of cardiac muscle. The strength of cardiac muscle contraction is a major […]